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Abstract:
Currently, there are no continuous, non-invasive blood glucose monitors. With over 366
million people worldwide expected to be diagnosed as diabetic by 2030, an alternative to the
current invasive methods is critical. This paper investigates the use of a discrete spectometric,
NIR reflectance glucometer to detect a change in glucose concentration in solution. At each
wavelength, an LED is used to emit light, and a reverse-biased LED detects light using
wavelengths 660 nm, 850 nm, 940 nm, 1450 nm, 1550 nm, 1650 nm. The discharge time of a
reverse-biased LED is proportional to the temporal integral of the detected light intensity.
The sensor’s response to changing glucose concentration was tested in both water and porcine
blood. Glucose concentration was increased by 0.5mmol l−1 and compared with a finger stick
glucometer. Each wavelength exhibited an expected change in adsorption given only an increase
in glucose concentration. The inverted exponential increase in absorption is explained by Beer
Lambert’s law. Wavelengths 660 nm, 850 nm and 1450 nm showed minimal change to absorption,
while 940 nm, 1550 nm and 1650 nm showed considerable change in absorption. The 1550 nm
LED gave the greatest increase in absorption with a 7% rise over 4.3mmol l−1 to 20.6mmol l−1.
Ratios of absorption responses (R1550/1650, R1550/1450 and R940/850) each gave proportional
increases in absorption with increasing glucose concentrations.
Keywords: Discrete NIR spectrometry, non-invasive, glucose sensor, LED-LED detection, Beer
Lambert’s Law
1. INTRODUCTION
Diabetes is a metabolic disorder resulting from the inabil-
ity of the body to regulate the level of glucose in the blood.
The prevalence of diabetes worldwide is ever increasing,
with over 366 million people expected to be diagnosed by
2030 (Wild et al., 2004). Currently, individuals with dia-
betes need to use invasive methods, such as finger pricks,
to monitor blood glucose concentration. The discomfort
and possible complications caused by these methods lead
to reduced frequency of monitoring by patients, reduc-
ing the effectiveness of diabetes prevention (Chowdhury
et al., 2013). The majority of continuous glucose monitors
(CGMs) require subcutaneous insertion of a filament for
electro-chemical measurement of local interstitial glucose
concentrations and require multiple calibrations each day.
They are complex and have significant drift and dynamics
(Zhou et al., 2018)
Futures in healthcare rely as much on enabling patient
self-management as on new innovative technologies. A
non-invasive glucose sensing method would facilitate more
patient monitoring, reducing complications and improving
quality of life.
 The project has received funding from EU H2020 R&I programme
(MSCA-RISE-2019 call) under agreement #872488 –DCPM
Continuous non-invasive glucose sensing has been a topic
of research for over 20 years (Liu et al., 2005). Techniques
such as near-infrared (NIR) spectroscopy have been stud-
ied, but as yet, there have been no commercialized prod-
ucts providing a solution (Poddar et al., 2008). Products
using NIR measurements have reported good correlation
with blood glucose, but too many of the estimations were
not clinically acceptable (Poddar et al., 2008; Smith, 2017;
Nybacka, 2016). Different proteins and molecules within
blood absorb different wavelengths of light to differing
extents, allowing estimation of concentration of each com-
pound (Delbeck et al., 2019).
The main difficulty in NIR detection is due to the weak ab-
sorption characteristics of glucose in a spectral region dom-
inated by absorption from water, haemoglobin and lipids
(Amerov et al., 2004). Conventional spectroscopy has
been investigated through the wavelength range of 500 nm
to 2000 nm with three main bands of interest: 2000 nm-
2500 nm (combination overtone), 1400 nm-2000 nm(first
overtone) and 750 nm-1400 nm (second overtone) (Yadav
et al., 2015). Yamakoshi and Yamakoshi (2006) developed
a pulse glucometer using spectrometry values from 900 nm
to 1700 nm. Through PLS methods, they gained accurate
results from glucose measurent, but required further work
on their instrumentation to take the sensor out of the
laboratory (Yamakoshi et al., 2009).
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Diabetes is a metabolic disorder resulting from the inabil-
ity of the body to regulate the level of glucose in the blood.
The prevalence of diabetes worldwide is ever increasing,
with over 366 million people expected to be diagnosed by
2030 (Wild et al., 2004). Currently, individuals with dia-
betes need to use invasive methods, such as finger pricks,
to monitor blood glucose concentration. The discomfort
and possible complications caused by these methods lead
to reduced frequency of monitoring by patients, reduc-
ing the effectiveness of diabetes prevention (Chowdhury
et al., 2013). The majority of continuous glucose monitors
(CGMs) require subcutaneous insertion of a filament for
electro-chemical measurement of local interstitial glucose
concentrations and require multiple calibrations each day.
They are complex and have significant drift and dynamics
(Zhou et al., 2018)
Futures in healthcare rely as much on enabling patient
self-management as on new innovative technologies. A
non-invasive glucose sensing method would facilitate more
patient monitoring, reducing complications and improving
quality of life.
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Fig. 1. Equivalent circuit diagram for the sensing diode
within LED-LED detection.
1.1 LED-LED Light Detection
Conventional methods of light detection use LEDs to emit
light and photodiodes to detect returning light. The cur-
rent is then amplified and converted to a voltage, and
sampled by a microprocessor through an analog to digital
converter (ADC) (Kennedy, 2015). The sensing method-
ology used here has a forward-biased LED to emit, and
a reverse-biased LED detect light. Rather than taking
instantaneous measurements with an ADC, the reverse-
biased LED uses its inherant capacitance to integrate
the incoming light intensity over the sensing period (Sto-
janovic and Karadaglic, 2013; Lau et al., 2006). Thus,
the output from the sensor represents the inverse of the
detected light intensity.
Lau et al. (2006) demonstrates that the lower photocurrent
producing efficiency of LEDs is an advantage as LED
detection provides approximately an order of magnitude
greater response to light intensity changes compared to
photodiodes. The spectral detection region of the LEDs
is also of slightly lower wavelength of the emission spec-
trum, creating a narrower detection range(O’Toole and
Diamond, 2008).
Recently, the LED-LED sensing method has been em-
ployed with success in absorbance measurements for de-
termining the concentration of solutions due to their spec-
trally sensitive absorption spectrum and their ease of im-
plementation (Shin et al., 2016). Figure 1 shows the basic
circuit diagram used in this study. Each wavelength to be
detected had a pair of LEDs, one emitting and the other
detecting the reflected light.
1.2 Beer-Lambert’s Law
Beer Lambert’s law describes the exponential attenuation
of light travelling through a substance. The attenuation of
light across a path length (d) is from the concentration
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ε: Absorption coefficients
c: Concentration of molecules
d: Optical path length
Blood consists of many constituents at varying concentra-
tions and absorption characteristics, meaning absorption




A(λ) represents the total absorbance through blood at a
particular wavelength (λ). By using different absorption
characteristics at varying wavelengths, the concentrations
of each constituent can be calculated (Zhang et al., 2016).
1.3 Detection Wavelength
To take advantage of the light absorption bands of glucose
at 750 nm-1400 nm, LEDs of wavelength 660 nm, 850 nm
and 940 nm were used. Haxha et al used a 940 nm LED to
monitor changes in glucose level (Haxha and Jhoja, 2016).
In this region, haemoglobin is the dominant absorber, so
any changes in blood oxygen level will skew the results
(Bashkatov et al., 2005). Thus, an 850 nm LED was chosen
because the isosbestic point of oxyhaemoglobin and de-
oxyhaemoglobin is at 800 nm, within the lower detection
spectrum (Chan et al., 2013). At the isosbestic point,
the absorption by haemoglobin is consistent, regardless
of the oxygen saturation. This wavelength was used to
account for the change in absorption by haemoglobin when
assessing the change in glucose at the same wavelength.
In the second absorption band, glucose has a dominant
absorption peak at 1550 nm as well as at 1650 nm. Figure
2 shows the approximate absorption by glucose, water,
lipids and albumin from 500 nm to 2000 nm. At 1450 nm
absorption is dominated by water, meaning variations in
concentrations of glucose and other blood constituents
cause a minimal change in absorption. At 1550 nm and
1650 nm, glucose is the dominant absorber, so a rise
in glucose level is expected to increase absorption at
these wavelengths. LEDs at 1550 nm and 1650 nm were
chosen as the absorption of lipids vary greatly, potentially
allowing extraction of the lipid concentration, which is also
clinically useful.
When calculating the change in absorption, the displace-
ment of water by glucose must be included (Amerov et al.,
2004). The relatively strong absorption properties of water
in the NIR spectrum causes significant changes in total
absorbance when glucose is added. Upon dissolution of glu-
cose, water molecules are displaced from the optical path
length. At wavelengths where water dominates absorption
(1450 nm), the total absorbance is expected to drop with
increasing glucose. At 1550 nm and 1650 nm, glucose is the
dominant absorber of light, so even with displacement of
water, the absorbance is expected to increase with glucose
concentration.
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Fig. 2. Absorption spectrum of the major light absorbers
in the NIR range, not to scale. Derived from (Yadav
et al., 2015; Amerov et al., 2004)
Fig. 3. Diagram of the developed glucose sensor.
2. METHODS
2.1 Sensor Design
To measure absorption of light at the required wave-
lengths, a sensor with 12 LEDs was built. Each of the
six wavelengths have an emitter and detector LED. The
sensor was designed in a rosette shape to ensure the
path of each wavelength travelled through the same space.
Figure 3 shows the sensor. The 660 nm and 940 nm
LEDs are contained in the same package to minimise
the footprint. An ATMEGA32U2 running at 16MHz
was used to power the emitting LED and to time the
discharge of the reverse-biased LED. The LEDs used
were XZM2MRTNI55W-8 (660,940 nm), 15412085A3060
(850 nm), MTSM5014-843-IR (1450 nm), MTSM5015-843-
IR (1550 nm) and MTSM5016-843-IR (1650 nm).
2.2 Beer-Lambert’s Law
While the intention of the sensor is to detect glucose in
pulsatile human blood, testing was first done in vitro
to verify a response to changing glucose. The 1450 nm
and 1550 nm wavelengths would be the focus as glucose
has no absorption at 1450 nm and dominant absorption
at 1550 nm. Compared to 1450 nm, the reflected light
intensity at 1550 nm should increase with the addition of
glucose. Thus, the ratio of 1450 nm and 1550 nm should
represent a Beer-Lambert response curve with increasing
glucose concentration. 1650 nm is also expected to increase
with glucose, but not as much as 1550 nm.
2.3 Water Testing
The first test conducted was with glucose added to de-
ionised water. To minimize the effect of outside variables
during testing, 40 litres of water was kept at body tem-
perature inside an insulated container. Glucose was added
in increments of 3.60 g to increase the concentration by
0.5mmol l−1 at each step. The concentration was increased
from 0mmol l−1 up to 20mmol l−1. The target physio-
logical range of blood glucose in a person is between
4mmol l−1 and 8mmol l−1. While blood glucose levels may
climb above 20mmol l−1 in hyperglycemic patients. Thus,
measuring a range from 0-20mmol l−1 provides a physio-
logically relevant range to show a response to glucose.
A sensor was placed in a resealable bag 200mm below
the surface of the water, minimising the effect of light
reflecting off the surface of the water. Upon each addition
of glucose, the water was stirred for 20 seconds and allowed
to come to a rest. Data were recorded over 30 seconds and
the average over this time was used for calculations. The
test was conducted in a dark room with no light source
other than the sensor.









Water 40.20 0 0.50 20.0
Blood 1 1.10 4.9 0.50 16.8
Blood 2 0.94 4.3 0.50 20.6
2.4 Pig Blood Testing
The next step in testing the sensor’s response to glucose
was to add glucose to blood under the same conditions as
the test in water. Two litres of pigs blood were used for
testing. To reduce the effects of clotting, 1.8 g of EDTA for
1 l of pig blood was added as an anticoagulant. The fresh
pig blood was kept in an insulated container between 0-
4 ◦C during transport and was raised to room temperature
for testing. An ACCU-CHEK Performa Glucometer was
used to measure the blood glucose content throughout
the test for sensor calibration. Table 1 gives the test
conditions. The sensor was mounted underneath the flask,
in contact with the glass.
The first test was done within 3 hours of obtaining the
fresh blood. Figure 4 shows the setup for both tests. The
first test had 1.1 l of blood and an initial blood glucose level
of 4.9mmol l−1. For each measurement, 0.09 g of glucose
powder was stirred into the blood for 30 seconds and
allowed to settle. One minute of data were recorded and
the average reading taken. The second test was conducted
two days after the first to further reduce the blood glucose
content. The blood stayed between 2-8 ◦C during waiting
period and was brought to room temperature for testing.
3. RESULTS
As the sensor integrates reflected light intensity during a
measurement, an increase in absorption is directly pro-
portional to an increase in discharge time of the receiving
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Fig. 2. Absorption spectrum of the major light absorbers
in the NIR range, not to scale. Derived from (Yadav
et al., 2015; Amerov et al., 2004)
Fig. 3. Diagram of the developed glucose sensor.
2. METHODS
2.1 Sensor Design
To measure absorption of light at the required wave-
lengths, a sensor with 12 LEDs was built. Each of the
six wavelengths have an emitter and detector LED. The
sensor was designed in a rosette shape to ensure the
path of each wavelength travelled through the same space.
Figure 3 shows the sensor. The 660 nm and 940 nm
LEDs are contained in the same package to minimise
the footprint. An ATMEGA32U2 running at 16MHz
was used to power the emitting LED and to time the
discharge of the reverse-biased LED. The LEDs used
were XZM2MRTNI55W-8 (660,940 nm), 15412085A3060
(850 nm), MTSM5014-843-IR (1450 nm), MTSM5015-843-
IR (1550 nm) and MTSM5016-843-IR (1650 nm).
2.2 Beer-Lambert’s Law
While the intention of the sensor is to detect glucose in
pulsatile human blood, testing was first done in vitro
to verify a response to changing glucose. The 1450 nm
and 1550 nm wavelengths would be the focus as glucose
has no absorption at 1450 nm and dominant absorption
at 1550 nm. Compared to 1450 nm, the reflected light
intensity at 1550 nm should increase with the addition of
glucose. Thus, the ratio of 1450 nm and 1550 nm should
represent a Beer-Lambert response curve with increasing
glucose concentration. 1650 nm is also expected to increase
with glucose, but not as much as 1550 nm.
2.3 Water Testing
The first test conducted was with glucose added to de-
ionised water. To minimize the effect of outside variables
during testing, 40 litres of water was kept at body tem-
perature inside an insulated container. Glucose was added
in increments of 3.60 g to increase the concentration by
0.5mmol l−1 at each step. The concentration was increased
from 0mmol l−1 up to 20mmol l−1. The target physio-
logical range of blood glucose in a person is between
4mmol l−1 and 8mmol l−1. While blood glucose levels may
climb above 20mmol l−1 in hyperglycemic patients. Thus,
measuring a range from 0-20mmol l−1 provides a physio-
logically relevant range to show a response to glucose.
A sensor was placed in a resealable bag 200mm below
the surface of the water, minimising the effect of light
reflecting off the surface of the water. Upon each addition
of glucose, the water was stirred for 20 seconds and allowed
to come to a rest. Data were recorded over 30 seconds and
the average over this time was used for calculations. The
test was conducted in a dark room with no light source
other than the sensor.









Water 40.20 0 0.50 20.0
Blood 1 1.10 4.9 0.50 16.8
Blood 2 0.94 4.3 0.50 20.6
2.4 Pig Blood Testing
The next step in testing the sensor’s response to glucose
was to add glucose to blood under the same conditions as
the test in water. Two litres of pigs blood were used for
testing. To reduce the effects of clotting, 1.8 g of EDTA for
1 l of pig blood was added as an anticoagulant. The fresh
pig blood was kept in an insulated container between 0-
4 ◦C during transport and was raised to room temperature
for testing. An ACCU-CHEK Performa Glucometer was
used to measure the blood glucose content throughout
the test for sensor calibration. Table 1 gives the test
conditions. The sensor was mounted underneath the flask,
in contact with the glass.
The first test was done within 3 hours of obtaining the
fresh blood. Figure 4 shows the setup for both tests. The
first test had 1.1 l of blood and an initial blood glucose level
of 4.9mmol l−1. For each measurement, 0.09 g of glucose
powder was stirred into the blood for 30 seconds and
allowed to settle. One minute of data were recorded and
the average reading taken. The second test was conducted
two days after the first to further reduce the blood glucose
content. The blood stayed between 2-8 ◦C during waiting
period and was brought to room temperature for testing.
3. RESULTS
As the sensor integrates reflected light intensity during a
measurement, an increase in absorption is directly pro-
portional to an increase in discharge time of the receiving
Fig. 4. Experimental setup for pig blood testing.
LED. This inverse relation is in contrast to conventional
photodiode measurement, where an increase in absorption
reduces the detected voltage. Figures 5 and 6 show the
time taken for each LED to discharge. A higher discharge
time results from higher absorption by light travelling
through the solution, and therefore higher concentration.
The value α is used to represent the proportionality be-
tween discharge time and light intensity.
4. DISCUSSION
4.1 Water Testing
Testing showed the predicted relationship between glucose
levels and light absorption. An increase in absorption
at 940 nm, 1550 nm and 1650 nm was recorded, while at
660 nm and 850 nm, there was a decrease in absorption.
Figure 5 plots the discharge time of each wavelength at
increasing glucose levels. At 1450 nm and 850 nm, the data
were very noisy with slight upwards and downwards trends
respectively over the range of glucose. At 660 nm there was
a slight decrease and at 940 nm, an increase. This increase
is due to the slight absorption peak at 940 nm.
4.2 Pig Blood Testing
Testing in blood gave different results to just water. Figure
6 shows that at 1450 nm and 1650 nm there was decreased
absorption with increasing glucose. This difference is rep-
resented in the change in absorption at 850 nm, as this
wavelength represents the total haemoglobin count. Ab-
sorption at 1450 nm, 660 nm, 940 nm and 1650 nm were
consistent between tests.
Table 2. Relative Reflection Intensity (α/ID)
readings for an empty flask
λ(nm) 660 860 940 1450 1550 1650
α/ID 0.72e5 0.40e5 0.21e5 2.63e5 2.17e5 0.54e5
As the sensor was placed in a resealable plastic bag, there
was a slight difference in absorption compared to glass.
Testing was done with an empty flask and the baseline
recording is shown in Table 2. All wavelengths except
for 1450 nm and 660 nm had lower responses without
blood. As the testing was done under ambient lighting,
the increase in 660 nm and 1450 nm is due to room lighting
and sunlight.
Fig. 5. Change in reflected light intensity in water with an
increase in glucose concentration.
4.3 Wavelength Ratios
The three main wavelength relationships of interest were
between 1450 nm and 1550 nm, 1550 nm and 1560 nm and
940 nm and 850 nm. At 1450 nm and 1550 nm is the great-
est difference between glucose absorbance coefficients and
at 940 nm and 850 nm is the isobestic point of haemoglobin
and a slight absorbance by glucose. At 1650 nm and
1550 nm, there is a difference in absorption by albumin and
lipids as well as glucose. In Figure 6, the noise variation in
readings are present in all wavelengths. Taking the ratio of
each wavelength pair removes the constant noise compo-
nent during each measurement such as ambient lighting.
Figure 7 shows the relationship to glucose. For better
comparison, each response is normalised and centred at
zero. The absorbance at 1650 nm has the largest decrease,
so the ratio of 1550 nm to 1650 nm was also calculated
(R1550/1650). This ratio gives the greatest response to the
normalised data, with R1550/1450 second greatest. R940/850
gives the lowest response to increasing glucose.
4.4 Beer Lambert’s Law
The response of each ratio in Figure 7 follows the inverted
Beer Lambert’s law. At low glucose concentrations of
glucose, reflected light intensity exponentially decreases.
As the only factor in Equation 1 that changes is the
concentration, the observed changes in light absorption
can be attributed solely to the addition of glucose. At
wavelengths with no glucose absorption peaks (660 nm,
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Fig. 6. Change in reflected light intensity in pigs blood
with an increase in glucose concentration.
Fig. 7. Normalised and centred absorbance ratios of
R1550/1650, R1550/1450 and R940/850 in pigs blood over
an increasing glucose level.
850 nm, 1450 nm), the reflected light intensity has minimal
change, providing further validation.
The development of a non-invasive blood glucose monitor
has been the focus of intense interest for several decades.
Among possible approaches, NIR spectroscopy has shown
much promise. However, definitive results have remained
elusive. This paper investigated the LEDs as light detec-
tors at selected spectral wavelengths, creating a discrete
spectrometer. The designed glucose sensor was tested in
water and pigs blood.
In water, the change in absorbance was solely due to the
increase in glucose concentration and the displacement
of water molecules. At 1650 nm and 1550 nm, the signal
gave the greatest rise in absorption. The response at
1450 nm was expected to reduce due to the displacement
of water. However, it remained noisy, slightly increasing
with glucose level. This high variation is likely due to
the minimal effect of water displacement due to glucose.
The high absorption of light by water at 1450 nm means
minimal light entering the solution returned to the sensor,
so the majority of the light returned will be reflected off
the surface of the water.
The intensity of reflected light was much higher for 660 nm
and 940 nm as water and glucose absorb minimally at
these wavelengths. Absorption of 660 nm and 940 nm light
in the pig blood were much higher due to the presence
of haemoglobin. It is also expected the glass of the flask
reduced the amount of reflected light reaching the sensor
as the LED discharge times for an empty flask were very
similar to those with blood present. The exact absorption
by the glass is not further explored as the purpose of this
paper is to measure a change in absorption with increasing
glucose concentrations, so a constant effect from glass does
not affect the conclusions.
Testing in pig blood yielded different absorption responses
to testing in water. The presence of haemoglobin reduced
the intensity of reflected light in the first absorption band
and the presence of other lipids and albumin in the blood
gave an opposite response than that of water at 1650 nm.
At 1650 nm, glucose, water, albumin and lipids have sim-
ilar absorption coefficients. As glucose displaces the other
molecules from the optical path, the corresponding in-
crease in absorption by glucose does not account for the
reduced absorption by displacement. Thus, the absorption
in blood at 1650 nm decreases with increasing glucose
levels. In contrast, the increased absorption from glucose at
1550 nm is more than the reduction in absorption from dis-
placement, so the overall absorption at 1550 nm increases
with increasing glucose concentration.
Ratios of absorbance at various wavelengths were calcu-
lated to test the response to glucose. Figure 7 shows that
the three ratios investigated all follow Beer Lambert’s law
for light absorption. The wavelength 1450 nm was chosen
for testing as water is the primary absorber. By comparing
the increasing absorbance at 1550 nm to the decreasing ab-
sorption at 1450 nm, the effect of glucose concentration can
be seen. Water has minimal absorption in the first absorp-
tion band, so the ratio between 940 nm and 850 nm shows
the relationship between glucose and haemoglobin. At the
isobestic point of haemoglobin (850 nm) the decrease in
absorption is due to the displacement of haemoglobin and
at 940 nm, the increase in absorption is from the increased
absorption of glucose. This behaviour can also be seen at
660 nm as absorbance decreases with increasing glucose.
The ratio of 1650 nm to 1550 nm gave the largest change
with increasing glucose in blood. Other than 1650 nm, all
other wavelength absorptions were as expected. Moving
forward, testing will be done in vivo to determine the
absorption response. The sensor will be designed for use
as a pulse glucometer, using the same principles as pulse
oximetry. In vivo testing will isolate the response in
the blood from the pulsatile signal, similar to work by
Yamakoshi et al. (2009).
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Fig. 6. Change in reflected light intensity in pigs blood
with an increase in glucose concentration.
Fig. 7. Normalised and centred absorbance ratios of
R1550/1650, R1550/1450 and R940/850 in pigs blood over
an increasing glucose level.
850 nm, 1450 nm), the reflected light intensity has minimal
change, providing further validation.
The development of a non-invasive blood glucose monitor
has been the focus of intense interest for several decades.
Among possible approaches, NIR spectroscopy has shown
much promise. However, definitive results have remained
elusive. This paper investigated the LEDs as light detec-
tors at selected spectral wavelengths, creating a discrete
spectrometer. The designed glucose sensor was tested in
water and pigs blood.
In water, the change in absorbance was solely due to the
increase in glucose concentration and the displacement
of water molecules. At 1650 nm and 1550 nm, the signal
gave the greatest rise in absorption. The response at
1450 nm was expected to reduce due to the displacement
of water. However, it remained noisy, slightly increasing
with glucose level. This high variation is likely due to
the minimal effect of water displacement due to glucose.
The high absorption of light by water at 1450 nm means
minimal light entering the solution returned to the sensor,
so the majority of the light returned will be reflected off
the surface of the water.
The intensity of reflected light was much higher for 660 nm
and 940 nm as water and glucose absorb minimally at
these wavelengths. Absorption of 660 nm and 940 nm light
in the pig blood were much higher due to the presence
of haemoglobin. It is also expected the glass of the flask
reduced the amount of reflected light reaching the sensor
as the LED discharge times for an empty flask were very
similar to those with blood present. The exact absorption
by the glass is not further explored as the purpose of this
paper is to measure a change in absorption with increasing
glucose concentrations, so a constant effect from glass does
not affect the conclusions.
Testing in pig blood yielded different absorption responses
to testing in water. The presence of haemoglobin reduced
the intensity of reflected light in the first absorption band
and the presence of other lipids and albumin in the blood
gave an opposite response than that of water at 1650 nm.
At 1650 nm, glucose, water, albumin and lipids have sim-
ilar absorption coefficients. As glucose displaces the other
molecules from the optical path, the corresponding in-
crease in absorption by glucose does not account for the
reduced absorption by displacement. Thus, the absorption
in blood at 1650 nm decreases with increasing glucose
levels. In contrast, the increased absorption from glucose at
1550 nm is more than the reduction in absorption from dis-
placement, so the overall absorption at 1550 nm increases
with increasing glucose concentration.
Ratios of absorbance at various wavelengths were calcu-
lated to test the response to glucose. Figure 7 shows that
the three ratios investigated all follow Beer Lambert’s law
for light absorption. The wavelength 1450 nm was chosen
for testing as water is the primary absorber. By comparing
the increasing absorbance at 1550 nm to the decreasing ab-
sorption at 1450 nm, the effect of glucose concentration can
be seen. Water has minimal absorption in the first absorp-
tion band, so the ratio between 940 nm and 850 nm shows
the relationship between glucose and haemoglobin. At the
isobestic point of haemoglobin (850 nm) the decrease in
absorption is due to the displacement of haemoglobin and
at 940 nm, the increase in absorption is from the increased
absorption of glucose. This behaviour can also be seen at
660 nm as absorbance decreases with increasing glucose.
The ratio of 1650 nm to 1550 nm gave the largest change
with increasing glucose in blood. Other than 1650 nm, all
other wavelength absorptions were as expected. Moving
forward, testing will be done in vivo to determine the
absorption response. The sensor will be designed for use
as a pulse glucometer, using the same principles as pulse
oximetry. In vivo testing will isolate the response in
the blood from the pulsatile signal, similar to work by
Yamakoshi et al. (2009).
5. CONCLUSION
A sensor was developed to measure the light absorption
by glucose in the NIR spectrum. Using discrete spec-
troscopy at 660 nm, 850 nm, 940 nm, 1450 nm, 1550 nm and
1650 nm, varied responses were found through testing in
both water and pig blood. The results obtained can be ex-
plained by Beer Lambert’s law as the only factor affecting
absorbance is the change in glucose concentration. The
glucose concentrations tested were within the expected
physiological range of blood glucose concentrations.
Using LED-LED detection methods, the sensor integrates
the reflected light intensity of the six wavelengths. The ra-
tio of R940/850 increases with glucose due to the absorption
peak at 940 nm and minimal change at the isobestic point
of haemoglobin (850 nm). In the first overtone, R1550/1450
gives an increase in absorption because glucose is the dom-
inant absorber at 1550 nm, while water is the only absorber
at 1450 nm. The final ratio calculated was R1550/1650 which
gave the greatest rise due to the displacement of other
absorbing molecules (lipids, albumin).
Future work on the sensor will involve an increase in out-
put light intensity to increase the amount of light reaching
the sensor. Non-invasive testing on pulsatile human blood
will be completed and compared to the absorption in water
and pig blood.
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